SYMBIOSIS C.M. LTD
General Data
Reg Number
516348679
Sector
Medical Devices
Established
2021
No. of Employees
5
Stage
Seed
Additional Funding
1
Description
Symbiosis is creating the first transcatheter mitral valve replacement implant, adjustable in real-time, addressing dynamic anatomical challenges. With 80% of patients remaining ineligible, the market need is significant, reaching $3B by 2027.
Technology
A mimicry that allows a valve to be replaced in the heart.
Targeted Customers
Hospitals, Healthcare companies, Physicians, Cardiologists.
Management personnel
Shira Burg (Zailerburg) - CEO & Co-Founder
Winning details
Route name
Winning year
The Expedited Program
The Expedited Program
2024
Startup Fund
Startup Fund
2024